当前位置：首页 > 文献互助 > 互助详情

Comparative Study of Branded and Generic Formulations of Bromocriptine Mesylate复制

用户bZt2HuJLLXp4 12天前 39 10 已关闭

DOI:复制

文献链接:复制

其他信息:

佐藤光利
応用薬理, 2006
cir.nii.ac.jp
Comparative Study of Branded and Generic Formulations of Bromocriptine Mesylate | CiNii
Research … CiNii Research自動翻訳機能(試行版)をCiNii Labsにて公開しました …
Comparative Study of Branded and Generic Formulations of Bromocriptine Mesylate …

上一篇：Small nucleic acid therapeutics: delivery breakthroughs, clinical translation, and future paradigms in precision medicine

下一篇：多囊卵巢综合征病证结合诊疗指南

互助时间线

2025-11-24 16:50:03 [关闭求助]

系统关闭了求助

2025-11-19 16:50:03 [发起求助]

最新发布的求助

Drugging the efferocytosis process: concepts and opportunities. 19分钟前
Characterization of CAR-T cellular kinetics and efficacy in solid tumor patients with and without prior lymphodepletion chemotherapy using a PBPK-PD model 2小时前
Comprehensive 3d Transition Metal Single‐Atom Modulation Tunes Ni‐MOF D‐Band for Alkaline OER 2小时前
Decoupling of nitrogen, phosphorus, and carbon release from fine and coarse roots during 7 years of decomposition 2小时前
A meta-analysis of albuminuria as a surrogate endpoint for kidney failure 3小时前
Tetrahedral Framework Nucleic Acid-Based Delivery of miR-34a Inhibitor for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis. 3小时前
A practical guide to large-scale docking 4小时前
Bicyclo[1.1.1]pentane-Derived Building Blocks for Click Chemistry 4小时前
Expanding Therapeutic Horizons in Parkinson's Disease Through MicroRNA-Based Interventions: A Comprehensive Review 4小时前
{Formulated Preparations- Specific Monographs} Rivastigmine Capsules - british pharmacopoeia[1731412457.779041.html] 5小时前
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China 6小时前
Phase II, Single-Center, Prospective Study of Intrathecal Thiotepa for the Prophylaxis of Secondary Central Nervous System Involvement in Highly Aggressive … 6小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com